Healio

PCOS blunts follicle-stimulating hormone increase after use of triptorelin during IVF

Please provide your email address to receive an email when new articles are posted on . Women with polycystic ovary syndrome have less increase in follicle-stimulating hormone after triptorelin ...
Medscape

FDA Approves 6-Month Formulation of Triptorelin for Prostate Cancer

March 15, 2010 — The US Food and Drug Administration (FDA) has approved a twice-yearly 22.5-mg formulation of triptorelin pamoate injection (Trelstar, Watson Pharmaceuticals, Inc) for the palliative ...
ascopubs.org

Treatment of aggressive prostate cancers in real life: Initiation, schedule, and management of triptorelin treatment (TALISMAN)—Design of the study.

Phase III randomized trial of PSMA PET prior to definitive radiation therapy for unfavorable intermediate-risk or high-risk prostate cancer [PSMA dRT]: Study protocol NCT04457245. Background: Prostate ...
technologynetworks

Pantec Reports Successful Phase I Study into the Delivery of Triptorelin Using P.L.E.A.S.E.® Technology

Pantec Biosolutions AG announced that it has achieved excellent results in a Phase I clinical trial of a triptorelin patch used in conjunction with the company’s novel P.L.E.A.S.E.® (Painless Laser ...